Oftalmo MD: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Oftalmo MD
Largest movements
- Financial fixed assets -€2.8m
down €2.8m (-57.6%), from €4.9m to €2.1m
- Cash +€356,784
up €356,784 (+1400.1%), from €25,483 to €382,267
mainly Investment in fixed assets (net) (+€2.8m) and Depreciation (+€41,563)
- Current investments +€262,544
up €262,544 (+5.5%), from €4.8m to €5.1m
- Profit (loss) carried forward -€1.9m
down €1.9m, from €1.8m to -€65,027
- Reserves -€200,517
down €200,517 (-5.1%), from €3.9m to €3.7m
- Taxes -€119,125
down €119,125 (-37.8%), from €314,916 to €195,791
- Gross operating margin -€41,277
down €41,277 (-4.9%), from €842,833 to €801,556
From the 2020 result to the 2021 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2020 and 2021 balance sheets and the 2021 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2020 | 2021 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,785,125 | €7,626,715 | -€2.2m | -22.1% |
| Fixed assets | 21/28 | €4,961,089 | €2,134,239 | -€2.8m | -57.0% |
| Tangible fixed assets | 22/27 | €101,089 | €74,239 | -€26,850 | -26.6% |
| Financial fixed assets | 28 | €4,860,000 | €2,060,000 | -€2.8m | -57.6% |
| Current assets | 29/58 | €4,824,036 | €5,492,476 | +€668,440 | +13.9% |
| Amounts receivable within one year | 40/41 | - | €47,569 | +€47,569 | |
| Current investments | 50/53 | €4,798,553 | €5,061,097 | +€262,544 | +5.5% |
| Cash at bank and in hand | 54/58 | €25,483 | €382,267 | +€356,784 | +1400.1% |
| Total equity and liabilities | 10/49 | €9,785,125 | €7,626,715 | -€2.2m | -22.1% |
| Equity | 10/15 | €9,626,553 | €7,557,601 | -€2.1m | -21.5% |
| Contributions | 10/11 | €3,880,000 | €3,880,000 | = | 0.0% |
| Reserves | 13 | €3,943,145 | €3,742,628 | -€200,517 | -5.1% |
| Profit (loss) carried forward | 14 | €1,803,408 | -€65,027 | -€1.9m | |
| Amounts payable | 17/49 | €158,572 | €69,114 | -€89,458 | -56.4% |
| Amounts payable after more than one year | 17 | €65,428 | €65,428 | = | 0.0% |
| Amounts payable within one year | 42/48 | €93,144 | €3,686 | -€89,458 | -96.0% |
| Trade debts | 44 | €5,845 | €3,686 | -€2,159 | -36.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €45,710 | €41,563 | -€4,147 | -9.1% |
| Gross operating margin | 9900 | €842,833 | €801,556 | -€41,277 | -4.9% |
| Operating profit (loss) | 9901 | €797,023 | €759,842 | -€37,181 | -4.7% |
| Recurring financial income | 75 | €706,756 | €167,571 | -€539,185 | -76.3% |
| Recurring financial charges | 65 | €3,029 | €575 | -€2,454 | -81.0% |
| Profit (loss) for the period before taxes | 9903 | €1,500,750 | -€1,873,162 | -€3.4m | |
| Income taxes | 67/77 | €314,916 | €195,791 | -€119,125 | -37.8% |
| Profit (loss) for the period | 9904 | €1,185,834 | -€2,068,953 | -€3.3m | |
| Profit (loss) for the period to be appropriated | 9905 | €1,185,834 | -€2,068,953 | -€3.3m |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2020 and 31 December 2021. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.